Description
FOXO4-DRI is an investigational senolytic peptide designed to selectively target and eliminate senescent “zombie” cells. By disrupting the interaction between FOXO4 and p53, it causes p53 to trigger apoptosis (programmed cell death) in damaged cells while sparing healthy tissue.






Reviews
There are no reviews yet.